Medication Augmentation of Sertraline for Anxiety Symptoms
Sertraline is treated as a first-line SSRI for generalized anxiety disorder (GAD) in guideline-based stepped care [1]. If sertraline is ineffective, management generally shifts to an alternative SSRI or an SNRI rather than routine medication “add-ons” [1]. If sertraline is not tolerated, pregabalin is an evidence-based option [1].
Medication Selection Algorithm
- Switch to an alternative SSRI or an SNRI when sertraline is ineffective [1].
- Consider pregabalin when SSRIs or SNRIs are not tolerated [1].
- Avoid benzodiazepines for GAD except as a short-term measure during crises [1].
- Do not use antipsychotics for GAD treatment in primary care [1].
- In complex, treatment-refractory cases, combinations of psychological and drug treatments or augmentation of antidepressants with other drugs may be considered with specialist expertise due to limited evidence and higher interaction burden [1].
Evidence Supporting This Recommendation
- For GAD, a NICE stepped-care pathway recommends an SSRI first and recommends switching within the SSRI/SNRI class after inadequate response [1].
- NICE recommends pregabalin specifically for people who cannot tolerate SSRIs/SNRIs [1].
- NICE recommends benzodiazepines only as short-term crisis treatment and recommends against routine benzodiazepine use for GAD [1].
- An American Family Physician review states that adding additional medications to antidepressants does not appear to improve outcomes for treatment-resistant anxiety disorders and notes no evidence of overall benefit to augmentation with benzodiazepines, atypical antipsychotics, or buspirone [2].
Monotherapy vs Combination Therapy
Monotherapy with an evidence-based antidepressant is the standard approach in earlier steps of care for GAD [1].
- Combination drug strategies or augmentation of antidepressants with other drugs are reserved for complex, treatment-refractory GAD and should be undertaken by practitioners with expertise because evidence for combination benefit is lacking and side effects and drug interactions are more likely [1].
Important Clarifications and Nuances
- For GAD treatment, failure of sertraline typically triggers an alternative SSRI or an SNRI rather than “stacking” additional anxiolytics in routine practice [1].
- Benzodiazepines for GAD should not be used beyond short-term crisis situations in guideline-based care [1].
Initiation Thresholds and Indications
- When sertraline is ineffective, guideline-based care recommends offering an alternative SSRI or an SNRI [1].
- When SSRIs or SNRIs are not tolerated, guideline-based care recommends offering pregabalin [1].
- Benzodiazepines are indicated only as short-term measures during crises [1].
Common Pitfalls to Avoid
- Routine long-term benzodiazepine therapy for GAD should be avoided in primary or secondary care [1].
- Routine augmentation of antidepressants with benzodiazepines or buspirone should not be assumed to improve outcomes in treatment-resistant anxiety disorders [2].
- Antipsychotics should not be used for GAD treatment in primary care [1].
Targets and Goals of Therapy
- The therapeutic goal in stepped care is improvement in GAD symptoms with ongoing medication monitoring and reassessment of response and adverse effects during early treatment [1].
- Continuation of effective medication for at least a year is recommended because relapse risk is high [1].